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Appendix Figure Legends 
 
Appendix Figure S1 – Modelling amino acid substitutions in ribosomal protein uS5.  
Visualization was done using PyMol v.1.8 (Schrödinger, Inc.) on the basis of available crystal 
structures. 
A Protein-protein interface uS4 (Rps9)-uS5 (Rps2) in the S. cerevisiae cytosolic ribosome; uS4 
and uS5 are shown in gold and green, respectively. 
B, C Sterical hindrance within the C-terminal domain of uS5 resulting from S200Y mutation; for better 
visualization the α-helices are shown as surface (Source: PDB 4V7R). 
D Protein-protein interface uS4 (RpsD)-uS5 (RpsE) in the E. coli ribosome. uS4 and uS5 are 
shown in gold and green, respectively. Residue A127 and mutation A127Y are marked in 
magenta. 
E, F Demonstrate sterical hindrance within the C-terminal domain of uS5 for the A127Y mutation 
(Source: PDB 4YBB). 
G Protein-protein interface mS40-uS5m (MRPS5) in the human mitochondrial ribosome; mS40 
and uS5m are shown in gold and green, respectively. Mitochondria-specific ribosomal protein 
mS40 structurally replaces uS4 in the mitoribosome. 
H, I Sterical hindrance within C-terminal domain of uS5m resulting from V336Y mutation (Source: 
PDB 3J9M).  
J Sequence alignment of E. coli and M. smegmatis ribosomal protein uS5 (RpsE). The mutated 
amino acid position (homolog of S. cerevisiae uS5 S200) is indicated – E. coli numbering A127, 
M. smegmatis numbering S152. 
K Sequence alignment of M. musculus and H. sapiens uS5m (MRPS5). The mutated amino acid 
position (homolog of S. cerevisiae uS5 S200) is indicated – H. sapiens numbering V336, M. 
musculus numbering V338. The nomenclature and spelling for ribosomal proteins and its 
encoding genes is given in the box [73]. 
 
Appendix Figure S2 
A Autoradiography of proteins immunoprecipitated with MT-CO1 Ab. In-vitro translation reactions 
of mitochondrial mutant A1555G hybrid ribosomes using MT-CO1 mRNA, MT-CO1-AGA-polyA 
mRNA, and 35S-Met labelling (lanes 2-5). Tobramycin was used at 5 µM. Lanes 1 and 6 are 
controls. Lane 1: 35S-Met labelled in-organello translation reaction; lane 6: MT-CO1 Ab 
immunoprecipitation of 35S-Met labelled in-organello translation. * indicates MT-CO1, ** 
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indicates MT-CO1 extended version. Schemed MT-CO1 and MT-CO1-AGA-polyA constructs 
used for in-vitro translation are given on top. 
B Western blot to determine cellular localization of myc-tagged MRPS5 protein. HEK293 cells 
were transiently transfected using MRPS5 WT or MRPS5 V336Y constructs; cell lysates were 
fractionated (T - total, C – cytosolic fraction, M - mitochondrial fraction). Myc-tag antibody (Ab) 
to detect MRPS5, HSP60 Ab as marker of proteins translated in the cytosol but localized in 
mitochondria, ATP6 Ab as marker for proteins translated and localized in mitochondria, β-
tubulin as marker for proteins translated and localized in the cytosol.  
C Mean GFP fluorescence of HEK cells stably transfected with MRPS5 WT or MRPS5 V336Y 
(n=8 clones each, + SD); ns, not significant (Student’s t-test).  
D Relative mRNA expression of MRPS5 transgene in comparison to endogenous MRPS5 in 
stably transfected HEK293 cells determined by qPCR (n=8 clones, + SD); ns, not significant 
(Student’s t-test).  
E Autoradiography of proteins immunoprecipitated with MT-CO1 Ab. In-vitro translation reactions 
using mutant A1555G hybrid ribosomes and MT-CO1 mRNA. Lane 1: 35S-Met labelled in-vitro 
translation reaction; lane 3: 35S-Cys labelled in-vitro translation. Representative figure used for 
quantification of 35S-Cysteine and 35S-Methionine ratio. Lane 2: In-organello translation reaction 
labelled with 35S-Met used as control for MT-CO1. 
F Validation of MT-CO1 and MT-CO2 antibodies used for immunoprecipitation. Lane 1: 
Autoradiography of in-organello mitochondrial translation labelled with 35S-Met; lane 2: 
Immunoprecipitation of in-organello translation products with MT-CO1 antibody; lane 3: 
Immunoprecipitation of in-organello translation products with MT-CO2 activity. Each antibody 
used immunoprecipitated the corresponding protein. 
G Validation of poly-lysine antibodies used for immunoprecipitation. In-vitro translation reactions 
using rabbit reticulocytes lysates, MT-CO1-TGA-polyA mRNA, MT-CO1-AGA-poly mRNA, and 
labelling with 35S-Met. Following in-vitro translation, proteins were immunoprecipitated with MT-
CO1 (lanes 1 and 2) and poly-lysine antibodies (lanes 3 and 4). As a control, beads without 
immobilized antibodies were used (lanes 5 and 6). In-organello mitochondrial translation 
products derived from HEK293 wild-type cells labelled with 35S-Met were used as control for 
MT-CO1 (lane 7). The poly-lysine antibody immunoprecipitated the MT-CO1 protein with an 
AGA arginine codon and a 3’ poly-lysine tail, but not the MT-CO1 protein with a TGA stop 
codon. For scheme of mRNA constructs used, see Fig. 1F. 
 
Appendix Fig S3 
A ATP content in HEK293 cells, MRPS5 WT and MRPS5 V336Y HEK cells (n=7 clones each, + 
SD); ns, not significant (Student’s t-test).  
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B Determination of mitochondrial mass using Mitotracker Red in HEK293 cells, MRPS5 WT and 
MRPS5 V336Y HEK293 cells (n=8 clones each, + SD); ns, not significant (Student’s t-test).  
C Measurement of mtDNA/nDNA ratio by qPCR in HEK293 cells, MRPS5 WT and MRPS5 V336Y 
HEK293 cells (n=8 clones, + SD); ns, not significant (Student’s t-test). 
D Oxygen consumption rate (OCR) in HEK293, MRPS5 WT and MRPS5 V336Y cell lines. Data 
were normalized to basal respiration in HEK293 cells, set to 100% (nMRPS5 WT=4, nMRPS5 V336Y=5, 
± SEM).  
E Generation time of E. coli WT and A127Y mutant (left panel, n=3), generation time of M. 
smegmatis WT and S152Y mutant (right panel, n=3); ns, not significant (Student’s t-test). 
F Translation efficiency in E. coli WT and S152Y mutant assessed by 35S-Met incorporation (n=3, 
+ SD); ns, not significant (Student’s t-test). 
G Ribosomal inhibition by emetine and linezolid selectively blocks cytosolic versus mitochondrial 
translation. Left: Autoradiography of emetine (100 µM) treated HEK293 cells after 0 and 30 min 
of incubation with 35S-Met versus emetine (100 µM) and linezolid (1 mM) treated HEK293 cells 
after 0 and 30 min of incubation with 35S-Met; emetine was used to inhibit cytosolic translation 
and linezolid was used to inhibit mitochondrial translation. * and ** indicate MT-CO1 and MT-
CO2 bands, respectively. Right: Quantitative analysis of 35S-Met incorporation by densitometric 
analysis (n=2). 
 
Appendix Fig S4 – Generation of Mrps5 mutant mice.  
A Southern blot strategy for detection of Mrps5FLEx alleles. Schematic representation of wild-type 
and Mrps5FLEx allele, restriction sites used for Southern blot are indicated.  
B Representative example of Southern blot analysis. The genomic DNA of seven mice was 
compared to wild-type DNA (WT). NheI digested DNA was blotted on nylon membrane and 
hybridized with the external 3’ probe indicated.  
C Southern blot strategy for detection of heterozygous induced mutant Mrps5V338Y/WT Knock-in 
mice. Schematic Southern blot representation of inducible mutant Mrps5 Knock-in allele, 
induced mutant Mrps5 Knock-in allele, and Mrps5 wild-type allele.  
D Representative example of Southern blot genotyping. Southern blot was performed using 
double AvrII/HpaI digestion of genomic DNA and hybridization with the external 5’ probe 
indicated to detect inducible and induced mutant Mrps5 allele and Mrps5 wild-type allele, WT 
controls are indicated.  
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E Presence of the point mutation in induced mutant Mrps5 Knock-in mice. Schematic 
representation of the PCR strategy, primers are specific for the induced mutant Mrps5 Knock-in 
allele. 
F Representative DNA sequencing result of Mrps5V338Y/WT induced mice, using genomic DNA as 
template.  
G Representative RT-PCR result of Mrps5V338Y/V338Y mice and WT mice. 
H Representative sequencing result of Mrps5V338Y/V338Y RT-PCR amplicon.  
I Mean values quantification (cDNA quantity) of Mrps5 transcripts in brain, inner ear and retina 
from Mrps5V338Y/V338Y mice and wild-type mice (n=5-6 animals, mean values + SD of cDNA 
quantity for wild-type and Mrps5V338Y/V338Y mice are represented, ns, not significant, Student’s t-
test). 
 
Appendix Fig S5 
A-D Activity in familiar and novel environments. 
E-H Sensory-motor function. 
I, J Exploration and anxiety. 
K Alternation rate in the T-maze. 
L Cue navigation in the water-maze. 
M, N Species-typical behaviors.  
Graphs show mean and ± SEM. Post-hoc FDR corrected ns p≥0.10, t-test for genotype within age 
cohorts. 34 mice, n=17 per genotype, n=9-13 per age cohort. 
A Normal diurnal change of activity in the home cage (ANOVA phase F1,28=412.8 p<0.0001). 
B Distance moved in the open field recorded in bins of 5 min (ANOVA: bin F3,72=46.19 
p<0.0001). 
C Light-dark transition test, distance moved while in the bright compartment.  
D Elevated O-maze, distance moved.  
E Average swim speed during the water-maze place navigation task.  
F Grip force, average of 10 trials.  
G Hot plate test, latency to lick hind paw.  
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H Acoustic startle response as function of stimulus intensity (64, 68, 72, 76, 80, 90, 100, 110, 120 
dB) (ANOVA: stimulus F2,32=3.315 p=0.0491, age F1,16=16.63 p=0.0009).  
I Open field, % of areas explored (ANOVA: genotype F1,25=11.51 p=0.0024, Post-hoc *p<0.05).  
J Elevated O-maze, % protected head dips.  
K T-maze, % alternation averaged across 6 trial pairs.  
L Water-maze cue navigation, swim path averaged across 12 training trials (ANOVA: 
F1,15=7.448 p=0.0155).  
M Nesting test, next quality score after 24 h.  
N Burrowing test, pellets removed after 24 h.  
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Appendix Table S1 – Cognate and near-cognate codons for cysteine and methionine in genes 
coding for MT-CO1 and MT-CO2 proteins. 
 
    COX1 COX2 
Methionine 
tRNA anti-codon  
CAU 
Cognate 32 10 
AUA 25 8 
AUG 7 2 
Near-cognate 48 26 
CUG 4 3 
GUG 3 0 
UUG 0 1 
AAG 1 0 
ACG 2 0 
AGG 0 0 
AUC 26 15 
AUU 12 7 
Cysteine  
tRNA anti-codon  
GCA 
Cognate 1 3 
UGU 0 1 
UGC 1 2 
Near-cognate 96 29 
CGC 2 1 
AGC 4 0 
GGC 17 4 
UUC 29 7 
UCC 10 4 
UAC 18 9 
UGA 16 3 
UGG 0 1 
 
 
